Filing Details
TELA Bio, Inc. (NASDAQ:TELA) filed a Form 8-K with the Securities and Exchange Commission on October 05, 2026, disclosing a material event.
8k filedNASDAQ:TELA
TELA Bio, Inc. (TELA) Reports Material Event to SEC
TELA Bio, Inc. (NASDAQ:TELA) filed a Form 8-K with the Securities and Exchange Commission on October 05, 2026, disclosing a material event.
At publication ·
What changed
TELA Bio, Inc. (NASDAQ:TELA) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- TELA Bio, Inc. filed a Form 8-K with the SEC on October 5, 2026, to disclose a material event requiring shareholder notification.
- TELA Bio stock trades at $1.14 per share with a market capitalization of $45.6 million.
- Form 8-K filings report material events such as leadership changes, material agreements, acquisitions, or asset sales between regular quarterly reports.
Market Context
TELA Bio, Inc.'s stock currently trades at $1.14 with a market capitalization of $45.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for TELA Bio, Inc.'s stock.
All SEC filings for TELA Bio, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TELA Stock Page
Frequently Asked Questions
Where can I read TELA's SEC filings?
Browse all filings on our TELA SEC filings page.
What types of SEC filings does TELA Bio, Inc. file?
Public companies like TELA Bio, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.